J.C. Penney Company Inc (JCP) 8.41 $JCP Stocks Slump at

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
J.C. Penney Company Inc (JCP) 8.41 $JCP

Stocks Slump at Close to Erase Dow, S&P 500 First-Quarter Gains
at The Street - 2 hrs 48 mins ago
Stock markets slump into the close on Tuesday, wiping out slight gains for the first quarter for both the Dow and S&P 500.
XLB: 48.78 (-0.49), CHTR: 193.11 (+9.72), FCX: 18.95 (-0.43), PCLN: 1,164.15 (+14.32), IBM: 160.50 (-2.17), TCK: 13.73 (-1.54), BHP: 46.47 (-0.71), JCP: 8.41 (+0.58), RIO: 41.40 (-0.97), DOW: 47.98 (-0.70), X: 24.40 (-1.04), XLE: 77.58 (-0.46)

Stock Markets Fall Amid Uncertainty Over Iran Nuclear Deal
at The Street - Tue Mar 31, 2:11PM CDT
Stocks slip slightly after Monday's rally as uncertainty over a Iran nuclear deal shakes commodity markets and U.S. economic data comes in mixed.
PHG: 28.34 (-0.43), IBM: 160.50 (-2.17), CHTR: 193.11 (+9.72), JCP: 8.41 (+0.58), X: 24.40 (-1.04), PCLN: 1,164.15 (+14.32)

Trade-Ideas: JC Penney (JCP) Is Today's "Storm The Castle" Stock
at The Street - Tue Mar 31, 1:14PM CDT
Trade-Ideas LLC identified JC Penney (JCP) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate
JCP: 8.41 (+0.58)

Cramer -- Limited Upside in J.C. Penney, Under Armour is 'Extraordinary'
at The Street - Tue Mar 31, 9:51AM CDT
TheStreet's Jim Cramer think analysts' bullish sentiment on J.C. Penney is 'gutsy,' but stays optimistic on the growth story for Under Armour and Nike.
UA: 80.75 (+0.84), NKE: 100.33 (-0.56), JCP: 8.41 (+0.58)

Here’s a Reason J.C. Penney (JCP) Stock is Rising Today
at The Street - Tue Mar 31, 9:35AM CDT
J.C. Penney (JCP) stock is higher after analysts at Piper Jaffray raised their price target and comp estimates on the company.
JCP: 8.41 (+0.58)

Piper Jaffray sees a big run for J.C. Penney
Seeking Alpha - at Seeking Alpha - Tue Mar 31, 7:04AM CDT

JCP: 8.41 (+0.58)

Coverage Update: We Can't Call A Top, So We Can't Let Go
Kevin Donovan - at Seeking Alpha - Mon Mar 30, 12:08PM CDT

WFM: 52.08 (-0.27), AMZN: 372.10 (-2.49), AVP: 7.99 (+0.09), RDEN: 15.60 (-0.08), M: 64.91 (+0.47), BKS: 23.75 (+0.04), KORS: 65.75 (-0.51), UA: 80.75 (+0.84), COH: 41.43 (-0.16), LB: 94.29 (+0.09), MAT: 22.85 (+0.20), TGT: 82.07 (-0.07), JCP: 8.41 (+0.58), GPS: 43.33 (+0.20), EL: 83.16 (-0.91)

Expansions In Both Store And Online Operations Will Benefit J.C. Penney
AH Research - at Seeking Alpha - Mon Mar 30, 7:17AM CDT

JCP: 8.41 (+0.58)

Comparing America's Next 3 Department Stores Companies
Joseph Cafariello - at Seeking Alpha - Mon Mar 30, 4:15AM CDT

DDS: 136.51 (-0.56), JCP: 8.41 (+0.58), SHLD: 41.38 (-1.09)

J.C. Penney Looks To Be Almost Out Of The Woods
Daniel Jones - at Seeking Alpha - Fri Mar 27, 10:15PM CDT

JCP: 8.41 (+0.58)

Critical Alerts For Bank of America, Novo Nordisk, Infinera Corporation, JC Penney and Realty Income Released By InvestorsObserver
PR Newswire - Fri Mar 27, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for BAC, NVO, INFN, JCP and O.
NVO: 53.39 (-1.29), JCP: 8.41 (+0.58), BAC: 15.39 (-0.13), O: 51.60 (-0.03), INFN: 19.67 (+0.26)

Next Support Level for JC Penney (JCP) is $7.85
Comtex SmarTrend(R) - Thu Mar 26, 9:35AM CDT
Shares of JC Penney (NYSE:JCP) have bearishly opened below the pivot of $8.00 today and have reached the first support level of $7.92. Should the shares continue to fall, the support pivots of $7.85 and $7.70 will be of interest.
JCP: 8.41 (+0.58)

UPDATE: Slyce Inc. Contracts with JCPenney to Provide Mobile Visual Search Technology
Marketwired - Wed Mar 25, 9:23AM CDT
Editors note: There is one video associated with this press release.
JCP: 8.41 (+0.58), SLC.VN: 0.530 (-0.010)

The Zacks Analyst Blog Highlights: Aeropostale, J.C. Penney, American Eagle Outfitters, Urban Outfitters and Rocky Brands - Press Releases
Zacks Equity Research - Zacks Investment Research - Tue Mar 24, 8:30AM CDT
The Zacks Analyst Blog Highlights: Aeropostale, J.C. Penney, American Eagle Outfitters, Urban Outfitters and Rocky Brands
URBN: 45.65 (-0.13), AEO: 17.08 (-0.06), RCKY: 21.60 (-0.05), JCP: 8.41 (+0.58), ARO: 3.47 (+0.14)

Look for Shares of JC Penney to Potentially Pullback after Yesterday's 4.16% Rise
Comtex SmarTrend(R) - Mon Mar 23, 4:54PM CDT
JC Penney (NYSE:JCP) traded in a range yesterday that spanned from a low of $7.67 to a high of $8.11. Yesterday, the shares gained 4.2%, which took the trading range above the 3-day high of $7.84 on volume of 14.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JCP: 8.41 (+0.58)

After Yesterday's Rally of 4.16% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Mar 23, 4:53PM CDT
JC Penney (NYSE:JCP) traded in a range yesterday that spanned from a low of $7.67 to a high of $8.11. Yesterday, the shares gained 4.2%, which took the trading range above the 3-day high of $7.84 on volume of 14.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
JCP: 8.41 (+0.58)

Retail Stocks Get Riskier? 3 Apparel Picks - Analyst Blog
Swarup Gupta - Zacks Investment Research - Mon Mar 23, 9:17AM CDT
Recent data suggests that despite risks, the popularity of retail stocks continues to rise.
URBN: 45.65 (-0.13), AEO: 17.08 (-0.06), RCKY: 21.60 (-0.05), SFLY: 45.24 (-0.64), JCP: 8.41 (+0.58), WFC: 54.40 (-0.37), ARO: 3.47 (+0.14)

Do Long-Term Earnings Estimate Changes Affect Stocks?
at Investor's Business Daily - Mon Mar 23, 7:02AM CDT
Do changes in long-term analyst consensus earnings estimates impact stock prices? As the fourth-quarter earnings season draws to a close, analysts at Wells Fargo Securities decided to compare 2015 EPS estimates of 51 retail stocks vs. the estimates...
AMZN: 372.10 (-2.49), UA: 80.75 (+0.84), RH: 99.19 (+0.12), JCP: 8.41 (+0.58), HBI: 33.51 (-0.15), KORS: 65.75 (-0.51), FIVE: 35.57 (+0.08), ARO: 3.47 (+0.14)

More swinging doors at J.C. Penney's C-suite
Seeking Alpha - at Seeking Alpha - Fri Mar 20, 9:14AM CDT

JCP: 8.41 (+0.58)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 16

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 12

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Women Through the Gettysburg Salon Experience

Updated Category News Views 116

Reimagining Women's Spaces Through the Gettysburg Salon The Gettysburg Salon is a vibrant platform where women can express themselves creatively and engage in thought-provoking dialogues. This initiative began with three passionate individuals who envisioned a safe space for women to explore their identities, aspirations, and challenges through art and conversation. In a...

Continue Reading
Transforming Off-Road Adventures: Upfit UTV and OMI Innovation

Updated Category News Views 165

Transforming Off-Road Adventures: Upfit UTV and OMI Innovation Upfit UTV, a subsidiary of Fox Factory known for customizing high-performance vehicles, has joined forces with OMI, a leader in electric powertrain engineering. Together, they are redefining off-road adventures with their groundbreaking Fusion-Drive technology. This innovation not only elevates performance but...

Continue Reading
Investor Alert: AstraZeneca Faces Class Action Lawsuit Under SEC Laws

Updated Category News Views 278

Investor Alert Regarding AstraZeneca Securities Class Action Kahn Swick & Foti, LLC, founded by former Attorney General Charles C. Foti, Jr., is highlighting crucial information for investors in AstraZeneca PLC (NASDAQ: AZN) who may have incurred losses exceeding $100,000. The firm reminds those affected that they need to file lead plaintiff applications for their class...

Continue Reading
Important Class Action for GSK plc Investors: Know Your Rights

Updated Category News Views 208

GSK Faces Class Action Lawsuit: Key Information for Investors Levi & Korsinsky, LLP has announced a class action securities lawsuit involving GSK plc, a well-known pharmaceutical company traded on the NYSE under the ticker GSK. This lawsuit is particularly significant for investors who have been adversely affected during a specified period concerning the securities of...

Continue Reading
Denny’s Fundraiser for No Kid Hungry: Making a Difference

Updated Category News Views 435

Denny’s Annual Fundraiser for No Kid Hungry Returns Denny’s is excited to bring back its annual in-restaurant fundraiser to support No Kid Hungry, a national initiative focused on ending childhood hunger in the United States. This campaign will run for a designated period, allowing Denny's restaurants to make a meaningful difference by ensuring that children have...

Continue Reading